UPDATE: BioMimetic Therapeutics (BMTI) Sees Upside on Stronger Volume
Tweet Send to a FriendGet Alerts BMTI Hot Sheet
Up)
Trade BMTI Now!
(Updated - June 22, 2012 11:12 AM EDT)
BioMimetic Therapeutics (Nasdaq: BMTI) vlatility is up 8.6 percet as shares run 15 percent higher early on the day.
Shares are getting above their 200-day DMA of $2.67.
This is the highest shares have been since last October.
UPDATE - Shares are moving following positive news Thursday that its Augment Injectable Bone Graft (AIBG) met its primary endpoint of non-inferiority of AIBG to autograft as assessed by CT scan at six months.
For more color, click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
BioMimetic Therapeutics (Nasdaq: BMTI) vlatility is up 8.6 percet as shares run 15 percent higher early on the day.
Shares are getting above their 200-day DMA of $2.67.
This is the highest shares have been since last October.
UPDATE - Shares are moving following positive news Thursday that its Augment Injectable Bone Graft (AIBG) met its primary endpoint of non-inferiority of AIBG to autograft as assessed by CT scan at six months.
For more color, click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- Apple (AAPL) Turns Positive
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
